A Randomized, Multicenter, Double‐Blind, Placebo‐Controlled Study of a Targeted Release Oral Cyclosporine Formulation in the Treatment of Mild to Moderate Ulcerative Colitis: Influence of Immunosuppressants at Baseline: 713. (October 2019)